WPRIM Management System> DCMS> Chinese Journal of Cardiology> 2020> 48> 4

Volume: 48 Issue: 4

1. Chinese expert consensus on lipid management of very high-risk atherosclerotic cardiovascular disease patients. Page:280—286
2. The importance of improving the approaches to diagnosis and treatment of cardiac amyloidosis. Page:265—270
3. Research progress on the wild-type transthyretin amyloidosis. Page:271—275
4. State-of-the-art review on the non-invasive diagnosis approaches of patients with transthyretin cardiac amyloidosis. Page:276—279
5. The role of three-dimensional speckle tracking imaging derived parameters on predicting outcome of hypertrophic cardiomyopathy patients with MYH7 mutations. Page:287—293
6. Long-term outcome of patients with hypertrophic obstructive cardiomyopathy post percutaneous transluminal septal ablation. Page:294—301
7. Impact of different admission ways on treatment efficiency in patients with acute ST-segment elevation myocardial infarction. Page:302—307
8. Risk factors for recurrent hospitalizations of patients with atrial fibrillation. Page:308—314
9. Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease. Page:315—322
10. Involvement of Src kinase in the down-regulation of ultra-rapid delayed rectifier K(+)current induced by tumor necrosis factor-α in cardiomyocytes. Page:323—328
11. MicroRNA-23a knockdown attenuates angiotensin Ⅱ induced hypertrophy in rat H9c2 cells via activating PTEN and AMPK pathway. Page:329—335
12. A case report of surgical treatment of right aortic valve perforation caused by interventional closure of ventricular septal defect. Page:336—338
13. Research progress on sodium-glucose co-transporter 2 inhibitors for the treatment of cardiovascular diseases. Page:339—343
14. How to optimize β-blocker therapy in heart failure patients complicating with chronic obstructive pulmonary disease? Page:344—348